|本期目录/Table of Contents|

[1]武晓静,陈玉霞,麻献华,等.利用CRISPR/Cas9技术体内标记示踪小鼠内源性NPC1L1蛋白[J].天津医科大学学报,2022,28(01):53.
 WU Xiao-jing,CHEN Yu-xia,MA Xian-hua,et al.Genetic labeling and tracing of mouse endogenous NPC1L1 protein by CRISPR/Cas9 technology in vivo[J].Journal of Tianjin Medical University,2022,28(01):53.
点击复制

利用CRISPR/Cas9技术体内标记示踪小鼠内源性NPC1L1蛋白(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
28卷
期数:
2022年01期
页码:
53
栏目:
基础研究
出版日期:
2022-01-20

文章信息/Info

Title:
Genetic labeling and tracing of mouse endogenous NPC1L1 protein by CRISPR/Cas9 technology in vivo
文章编号:
1006-8147(2022)01-0053-05
作者:
武晓静1陈玉霞2麻献华2章卫平12
(1.天津医科大学朱宪彝纪念医院,天津市内分泌研究所,国家卫健委激素与发育重点实验室,天津市代谢性疾病重点实验室,天津300134;2.海军军医大学基础医学院病理生理学教研室,上海 200433)
Author(s):
WU Xiao-jing1CHEN Yu-xia2MA Xian-hua2ZHANG Wei-ping12
(1.NHC Key Laboratory of Hormones and Development,Tianjin Key Laboratory of Metabolic Diseases,Chu Hsien-I Memorial Hospital, Tianjin Institute of Endocrinology,Tianjin Medical University,Tianjin 300134,China; 2.Department of Pathophysiology,College of Basic Medical Science,Navy Medical University,Shanghai 200433,China)
关键词:
NPC1L1CRISPR/Cas9胆固醇吸收示踪转基因小鼠标签蛋白
Keywords:
NPC1L1CRISPR/Cas9cholesterol absorptiontracing transgenic micetag protein
分类号:
R589.2
DOI:
-
文献标志码:
A
摘要:
目的:对小鼠内源性NPC1L1蛋白进行标记和示踪,为研究体内胆固醇的吸收机制提供新的技术手段。方法:利用CRISPR/Cas9基因组编辑技术,针对小鼠NPC1L1基因的3′末端非编码区,设计不同sgRNA,利用细胞内的荧光素酶法,检测分析其Cas9/sgRNA核酸酶活性,筛选出高活性的sgRNA序列,经体外转录制备sgRNA和Cas9 mRNA。PCR扩增基因打靶的两侧同源臂,与FLAG-EGFP的编码cDNA一起克隆至打靶载体。经酶切和测序鉴定正确的打靶载体DNA与sgRNA、Cas9 mRNA一起显微注射入小鼠受精卵,移植至假孕小鼠体内自然发育;通过基因组DNA 的PCR和Southern 印迹分析,筛选、鉴定重组正确且无随机插入的子代小鼠。制备小肠组织冰冻切片,荧光显微镜下观察NPC1L1-EGFP的表达分布。结果:成功构建了NPC1L1基因敲入打靶载体,筛选了高活性的sgRNA,利用CRISPR/Cas9技术获得了对内源性NPC1L1蛋白C端进行FLAG和EGFP双重标记的子代小鼠,荧光显微镜下观察到该融合蛋白分布于小肠绒毛上皮细胞的刷状缘,与NPC1L1的分布特征一致。结论:成功实现了对小鼠内源性NPC1L1蛋白进行体内标记,为研究NPC1L1囊泡转运和胆固醇吸收机制提供了有效手段。
Abstract:
Objective: To label and trace endogenous NPC1L1 protein in mouse model,providing a new tool for studying the absorption mechanisms of cholesterol in vivo. Methods:Using CRISPR/Cas9 genomic editing technology,different sgRNAs were designed according to the 3′ untranslated region of mouse NPC1L1 gene. The activity of Cas9/sgRNA nuclease was analyzed in cellular luciferase detection system,and the sgRNA sequence with high activity was screened out.The sgRNA and Cas9 mRNA were transcribed in vitro. The two homologous arms of the target gene were amplified by PCR and cloned into the target vector together with the cDNA encoding FLAG-EGFP. The correct targeting vector identified by restriction enzyme digestion and sequencing,along with sgRNA and cas9 mRNA were microinjected into fertilized eggs and then transplanted into pseudopregnant mice for natural development. The offspring mice with correct recombination and no random insertion were verified by PCR and Southern blotting analysis of genomic DNA. The expression of NPC1L1-FLAG-EGFP fusion protein was observed under fluorescence microscope using jejunal cryosections. Results: The FLAG-EGFP knock-in targeting vector of NPC1L1 gene was successfully constructed. The highly active sgRNA was determined,and the offspring mice with FLAG and EGFP dual-tags on the C-terminal of endogenous NPC1L1 protein were finally obtained by CRISPR/cas9 technology. The localization of the fusion protein along the brush border of villous epithelial cells in the small intestine was observed under fluorescence microscope,which was consistent with the distribution characteristics of NPC1L1. Conclusion: The successfully constructed mouse model with endogenous NPC1L1 protein labeling of dual-tags,FLAG and EGFP provides an effective tool to study the mechanism of vesicle transport and cholesterol absorption of NPC1L1 in vivo.

参考文献/References:

[1] ALTMANN S W,DAVIS HR J R,ZHU L J,et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption[J]. Science,2004,303(5661):1201
[2] DAVIES J P,SCOTT C,OISHI K,et al. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia[J]. J Biol Chem,2005,280(13):12710
[3] ZHANG J H,GE L,QI W,et al. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake[J]. J Biol Chem,2011,286(28):25088
[4] TEMEL R E,TANG W,MA Y,et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe[J]. J ClinInvest,2007,117(7):1968
[5] GE L,QI W,WANG L J,et al. Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake[J]. Proc Natl Acad Sci U S A,2011,108(2):551
[6] LI P S,FU Z Y,ZHANG Y Y,et al. The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1[J]. Nat Med,2013,20(1):80
[7] WEI J,FU Z Y,LI P S,et al. Theclathrin adaptor proteins ARH,Dab2,and Numb play distinct roles in Niemann-Pick C1-Like 1 versus low density lipoprotein receptor-mediated cholesterol uptake[J]. J Biol Chem,2014,289(48):33689
[8] XIE C,LI N,CHEN Z J,et al. The small GTPase Cdc42 interacts with Niemann-Pick C1-like 1 (NPC1L1) and controls its movement from endocytic recycling compartment to plasma membrane in a cholesterol-dependent manner[J]. J Biol Chem,2011,286(41):35933
[9] ZHANG Y Y,FU Z Y,WEI J,et al. A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption[J]. Science,2018,360(6393):1087
[10] XIE P,ZHU H,JIA L,et al. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels[J]. Atherosclerosis,2014,237(2):609
[11] TANG W,JIA L,MA Y,et al. Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver[J]. Biochim Biophys Acta,2011,1811(9):549
[12] XIE P,JIA L,MA Y,et al. Ezetimibeinhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice[J]. Arterioscler Thromb Vasc Biol,2013,33(5):920

相似文献/References:

[1]刘郁莹,崔晓腾,高星杰,等.利用改良的CRISPR/Cas9基因编辑系统构建HeLa细胞SND1基因敲除稳定株[J].天津医科大学学报,2015,21(06):480.
 LIU Yu-ying,CUI Xiao-teng,GAO Xing-jie,et al.Construction of HeLa SND1 knockout gene stable strain by using modified CRISPR/Cas9 gene editing system[J].Journal of Tianjin Medical University,2015,21(01):480.
[2]张 静,高 雅,李新宇,等.SUZ12过表达及敲减恶性外周神经鞘瘤稳定细胞株的建立及其意义[J].天津医科大学学报,2019,25(05):429.
 ZHANG Jing,GAO Ya,LI Xin-yu,et al.Establishment and significance of SUZ12 overexpression and knockdown of stable malignant peripheral nerve sheath tumor cell lines[J].Journal of Tianjin Medical University,2019,25(01):429.
[3]张佳慧,阎晗,胡德庆.利用CRISPR/Cas9技术构建Aff4基因敲除B16-F10细胞系及AFF4的多克隆抗体制备[J].天津医科大学学报,2023,29(04):372.
 ZHANG Jia-hui,YAN Han,HU De-qing.Aff4 gene knockout stable B16-F10 cell line generation with CRISPR/Cas9 system and anti-AFF4 polyclonal antibody preparation[J].Journal of Tianjin Medical University,2023,29(01):372.
[4]杨欢,冯玉梅.FOXQ1敲除乳腺癌MCF7细胞株的构建及其功能初探[J].天津医科大学学报,2023,29(05):500.
 YANG Huan,FENG Yu-mei.Construction of FOXQ1 knockout MCF7 breast cancer cell line and itspreliminary functional exploration[J].Journal of Tianjin Medical University,2023,29(01):500.
[5]董玥湘,刘岩,靳小石,等.应用CRISPR/Cas9技术敲除SLC5A8基因对黑色素瘤的影响[J].天津医科大学学报,2024,30(02):128.[doi:10.20135/j.issn.1006-8147.2024.02.0128]
 DONG Yuexiang,LIU Yan,JIN Xiaoshi,et al.Effect of knockdown of SLC5A8 gene on melanoma by applying CRISPR/Cas9 technology[J].Journal of Tianjin Medical University,2024,30(01):128.[doi:10.20135/j.issn.1006-8147.2024.02.0128]

备注/Memo

备注/Memo:
基金项目 国家重点研发计划(2019YFA0802503);国家自然科学基金重大研究计划(91857203)
作者简介 武晓静(1994-),女,硕士,研究方向:肠道胆固醇代谢的分子机制研究;通信作者:章卫平,E-mail: zbtb20@aliyun.com。
更新日期/Last Update: 2022-01-20